Cover Image

The Burrill Report (formerly Burrill Biotechnology Report Monthly)

Notice
This publication has been discontinued on October 8, 2013.

Abstract

In The Burrill Report you will find how life science companies are faring with their cash positions, whether or not the IPO market is returning and what companies are doing about it; how emerging technology promises to revolutionize vaccines, and what's happening in the realm of new antibiotics.

Our regular features include:

  • Venture financings
  • Public Financings
  • Grants
  • Partnering and licensing deals
  • Mergers and acquisitions
  • Nasdaq non-compliance notices and regained compliance
  • FDA new product approvals
  • Upcoming PDFUA dates
  • Layoffs and hirings
  • Executive changes
  • Bankruptcies and liquidations
  • Legal news
  • Patent news
  • Research news

And a rundown on the Burrill family of life science indices.

Show More
Pricing
Not Available
Get Notified
Email me when related reports are published